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Abstract
Background: Neglected Tropical Diseases (NTDs) afflict around one billion individuals in the poorest parts of the world
with many more at risk. Lymphatic filariasis is one of the most prevalent of the infections and causes significant morbidity
in those who suffer the clinical conditions, particularly lymphedema and hydrocele. Depressive illness has been
recognised as a prevalent disability in those with the disease because of the stigmatising nature of the condition. No
estimates of the burden of depressive illness of any neglected tropical disease have been undertaken to date despite the
recognition that such diseases have major consequences for mental health not only for patients but also their caregivers.
Methods: We developed a mathematical model to calculate the burden of Disability- Adjusted Life Years (DALY)
attributable to depressive illness in lymphatic filariasis and that of their caregivers using standard methods for
calculating DALYs. Estimates of numbers with clinical disease was based on published estimates in 2012 and the
numbers with depressive illness from the available literature.
Results: We calculated that the burden of depressive illness in filariasis patients was 5.09 million disability-adjusted
life years (DALYs) and 229,537 DALYs attributable to their caregivers. These figures are around twice that of 2.78
million DALYs attributed to filariasis by the Global Burden of Disease study of 2010.
Conclusions: Lymphatic filariasis and other neglected tropical diseases, notably Buruli Ulcer, cutaneous
leishmaniasis, leprosy, yaws, onchocerciasis and trachoma cause significant co morbidity associated with
mental illness in patients. Studies to assess the prevalence of the burden of this co-morbidity should be
incorporated into any future assessment of the Global Burden of neglected tropical diseases. The prevalence
of depressive illness in caregivers who support those who suffer from these conditions is required. Such
assessments are critical for neglected tropical diseases which have such a huge global prevalence and thus
will contribute a significant burden of co-morbidity attributable to mental illness.
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Background
The impact of mental illness on the sufferers of Neglected
Tropical Diseases (NTDs) appears to have been completely
disregarded as a cause of morbidity and was not quantified
in recent estimates in the Global Burden of Disease (GBD)
study [1, 2]. Estimates of burden of NTDs have focused on
the pathology and the contribution of disease sequelae to
morbidity and premature mortality in the calculation of
disability-adjusted life years (DALYs) [1, 2]. However, we
have recently highlighted the extent of mental illness on
sufferers of NTDs, which cause chronic sequelae and long-
term often stigmatising conditions as a consequence of irre-
versible pathology [3]. The characteristics of chronic NTDs
include the inability to work of both patients and care-
givers; a change to less productive employment resulting in
reduced or lack of income; a burden of debt through cata-
strophic and often inappropriate health expenditure; an in-
ability to pay for schooling thereby impacting on the life
time consequences for children; and a reduced societal role.
Associated stigma often prevents patients from playing a
full role in society or from leading a fulfilling emotional life,
often with reduced marital prospects impacting patients
and families with potential lifelong continuity of care from
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failure of women to marry with repercussions not only for
the patient but also the family [3–5].
The latest GBD study [1] attributes mental and be-
havioural disorders as 7.4 % in 2010 of the total GBD
of which 2.5 % was due to major depressive disorders
and 1.1 % to anxiety disorders. In these calculations it
is unclear if any burden is attributable to the mental
health of those suffering from an NTD has been in-
cluded. Hotez et al. [2] reviewed the Burden of NTDs
[1] but did not include in any of the estimates the bur-
den of mental health associated with NTDs. The GBD
of 2010 [1] attributes to NTDs 1 % of the total global
DALYs (excluding malaria) but the burden of NTDs
varies regionally by a factor of 961 reflecting the rela-
tive importance of these diseases in the impoverished
tropics where NTDs are amongst the commonest in-
fections and where transmission remains intense. The
GBD states “as most of these diseases cause limited
mortality” a statement that we dispute, the NTDs high-
light why quantification of disability from diseases is
important. The follow up paper on NTDs [2] and the
GBD study point out the apparent shift in global burden
of disease from communicable to non- communicable dis-
eases - a conclusion that impacts global health policy rec-
ommendations. However, the role of NTDs in causing
cancers (schistosomiasis, food borne trematodes),
cardiovascular and liver disease, neurological sequelae
(human African trypanosomiasis, neurocysticercosis)
and injuries (rabies and snake bite), are well recognised
[6]. The impact on mental health of these outcomes of
NTD infection has been ignored or disregarded in bur-
den estimates [1, 2]. Furthermore, an unstudied dimen-
sion of NTDs, which has significant additional burden
on poor communities, is that of the problems faced by
caregivers who are committed to the long-term care of
the disabled and who also suffer from the problems as-
sociated with both the direct and indirect costs of care
[3]. A search of the literature has failed to find any
study that examines the mental health of the caregivers
of those suffering the chronic pathology of NTDs [3].
Studies in India on the burden of depression in care-
givers of totally blind patients recorded a prevalence of
depression of 48 % [7]. In the case of those with visual
impairment, studies on the rates of depressive illness and
diminished quality of life have been conducted, but until
the recent study in India, a quantitative evaluation burden
and depression in caregivers does not appear to have been
undertaken in a developing world setting. There is a body
of literature evaluating the problems faced by caregivers of
patients with HIV/AIDs [8] and geriatric conditions [9, 10]
and a number of well-defined instruments and methodolo-
gies for evaluating the care burden exist [9, 10]. The recent
publication by World Health Organization (WHO) [8]
on the “Lymphatic Filariasis: Managing Morbidity and
Preventing Disability” states that “The psychological
effects of lymphatic filariasis have been poorly recog-
nized” and suggests a set of activities for psychological
support for patients and for socioeconomic rehabilita-
tion [11]. However, within the context of resource poor
rural settings, there is unlikely to be either the specialist
skills or resources to implement such support given the al-
most complete dearth of psychological or psychiatric ex-
pertise in such settings particularly in sub-Saharan Africa.
Studies on filariasis patients reports prevalence of de-
pression or feelings of inferiority as high as 97 % in India
[12]; in Togo, [13] 70 % of sufferers ranked high on the
Duke Depression scale; in Haiti, 37 % were at risk of de-
pression [14] although only 8 % prevalence was recorded
in Sri Lanka [15]. Recent studies in Ethiopia [16] on
podoconiosis have shown that patients suffering from the
clinically similar lymphedema (notwithstanding the differ-
ent aetiology) documented a higher burden of mental dis-
tress compared with healthy controls. The term mental
distress in this study was defined as any form of emotional
suffering due to podoconiosis and was deemed a more ap-
propriate measure rather than a specific psychiatric diag-
nosis within the social and cultural setting of the study. In
this paper, we present an estimate of the Global Burden of
Mental illness associated with lymphatic filariasis based
on the published figures of depressive illness from the
studies quoted above [12–15], and include the estimates
of depression, which can be attributed to caregivers based
on estimates of the need for care by chronically disabled
patients with filariasis.
Methods
We abstracted estimates from the literature on lymphatic
filariasis to populate our models. We used the WHO’s
framework of burden of disease in terms of DALYs to esti-
mate the mental health burden of lymphatic filariasis
among patients and their caregivers. We calculated DALYs
as the sum of Years of Life Lost (YLL) and Years Lost due
to Disablity (YLD). YLD, is in turn, the product of the
prevalence of the condition and the disability weights. Con-
ceptually, the burden of depression attributed to filariasis
represents a proportion of the total burden of filariasis, and
is the sum of YLL and YLD for depression attributed spe-
cifically to filariasis. We abstracted estimates from the lit-
erature [17, 18] to populate our disease burden model, and
used disability weights for mild, moderate and severe de-
pression from the GBD [17].
Results
The most recent estimate in 2012, which recognises the
impact of the Global Programme to eliminate lymphatic
filariasis, suggests 67.88 million people are infected with
lympathic filariasis, 36.11 million with clinical illness,
19.43 million with genital hydrocele, and 16.68 million
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with lymphedema [19]. This is a decline from the previ-
ously quoted figures of WHO when the Global Programme
to Eliminate the diseases began in 2000 when 119 million
were estimated to be infected in 1996 with 43 million
showing clinical symptoms (hydrocele and lymphedema).
The DALYs attributable to lymphatic filariasis in the GBD
study [1] were 2.78 million, based on a disability weight of
0.11 and 36 million cases (95 % confidence internal: 34–39
million) in 2010. In our studies to calculate the burden of
depressive illness, we used disability weights of 0.159 for
mild depression, 0.406 for moderate depression, and 0.655
for severe depression [17, 18]. Using a figure of 50 % that
those with clinical illness suffer severely enough to cause
depression, the prevalence of depression among patients
with lymphatic filariasis was estimated at 18.1 million. This
was based on the four studies of the mental illness in
filariasis patients in the literature where the prevalence
of depressive illness was 97 % in South India; 70 % in
Togo; 37 % in Haiti and 8.5 % in Sri Lanka [12–15].
We used a conservative distribution estimate of ten
million, seven million and one million for mild, moder-
ate and severe depression, respectively. The studies
from the above countries did not provide detailed
breakdowns for the level of depression reported hence
we chose a conservative set of estimates with only one
million out of the 18 million sufferes of depression be-
ing regarded as having severe depression the majority
only suffering mild depression. Clearly a higher figure
of severe depression given the higher DW would result
in a much higher estimate of burden. We estimated
YLD to be 1.59 million, 2.84 million and 655,000 for
these levels of depression severity, totalling 5.09 mil-
lion DALYs. Because mortality directly attributable to
lymphatic filariasis is rare although suicidal ideations
have been reported, and because the GBD classified no
deaths from depression in 2010, we assumed that YLL
is close to zero. As a result, the total DALYs estimated
from depression attributed to lymphatic filariasis is es-
timated at 5.09 million (Appendix A).
We then estimated mental burden of lymphatic filariasis
among caregivers using similar assumptions (Appendix B).
We further assumed that among the 36.1 million with clin-
ical symptoms, five million will suffer severely enough to
require a caregiver. Further assuming that one caregiver ex-
ists for each patient with severe symptoms, we estimated
the total number of caregivers as five million which could
be an underestimate. In a study of caregivers of blind indi-
viduals, 48 % had depression. To provide a conservative es-
timate, we assumed 25 % of caregivers of patients with
lymphatic filariasis to have depression. We further assumed
that caregivers with severe depression will select themselves
out of the role of caregiving due to the disability associated
with severe depression. Therefore, we assumed caregivers
will have only mild or moderate depression. With a
distribution of 90 % with mild depression and 10 % with
moderate depression, we estimated the YLD as 178,887 and
50,750, for a total of 229,537. Because the GBD does not
classify any deaths as attributable to depression, we approx-
imated YLL as zero. As a result, the burden of depression
among caregivers of patients with lymphatic filariasis is ap-
proximately 229,537 DALYs.
Discussion
This paper is the first to attempt to quantify the burden of
mental illness caused by an NTD, and indeed with one of
the most prevalent of these diseases -lymphatic filariasis
where, despite progress towards elimination [19, 20] with at
least 4.9 billion treatments already given to around one
billion people, millions with clinical disease remain [20].
We consider that the co-morbidity associated with mental
illness of NTDs [3] is a seriously underestimated dimension
of the global disease burden of many NTDs. We also
recognize that there are limitations in the study given the
paucity of data available to produce more accurate esti-
mates of depressive illness for LF as well as other NTDs.
However, given that LF is endemic in some 70 plus coun-
tries and notwithstanding the success of the Global
Programme to eliminate the disease we believe that using
the available data from what WHO considers as one of the
most disabling infections represents an important starting
point to encourage the need for more detailed studies not
only in LF but also other NTDs. We also justify the inclu-
sion of data on caregivers as an example of the total neglect
of this aspect of co-morbidity as a result of NTDs. The
GBD study of 2010 [1] and the recent evaluation of the
NTD burden [2] did not address the mental health morbid-
ity of NTDs. In addition, the mental health consequences
of NTDs have not been considered in the overview of men-
tal health and substance use disorders [21] in the GBD
2010 study, nor were NTDs considered in a major review
of mental disorders in 2008 [22]. Given the numbers who
suffer globally from the consequences of NTDs we consider
this a major omission in any debate. The DALY burden of
lymphatic filariasis was calculated as 2.78 million [1, 2]. We
have used in our calculations the estimates of Ramaiah and
Ottesen [19] of 2012 data, which recognise the impact of
the Global LF Elimination Programme following 12 years
of implementation of mass drug administration in 60 coun-
tries and where annual treatments in 2013 was 410 million
reported by countries [20]. The figures for the numbers of
individuals treated and the impact of the GPELF are pro-
vided in [19] but there are only a small number of papers
in the published literature that provided prevalence data on
mental health amongst those with clinical filariasis; it was
thus necessary to make some conservative assumptions
based on the wide range of prevalence of mental illness re-
ported [12–15]. We recognize that the four studies which
we used to inform our calculations from diverse settings
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cannot be considered as necessarily representative. How-
ever they are the only studies available on which to base
calculations. Given that we have estimated that 50 % of
those suffering from filariasis had an overall prevalence of
depression we consider that figure a conservative estimate.
This figure, however, could be much higher as for example
the study in India recorded 97 % depressive illness in pa-
tients. Given that the numbers of LF cases in India is the
highest in the world then our estimates could be considered
significantly higher than we calculated. In addition, follow-
ing an earlier study, we have estimated a further burden of
associated depression based on the role that caregivers play
in patient support. We also consider that the limitations of
the estimates of depression in caregivers must be recog-
nized. However, we include these results as patient depend-
ency on care when severly disabled has not been
recognized in any study of NTDs. Again we have been cau-
tious about the parameters we have chosen to make these
calculations but emphasise that further studies are needed
not only in lymphatic filariasis but also in other NTDs
where care of sufferers is necessary with consequent impli-
cations for families and communities.
Our estimate of 5.09 million DALYs of the burden as-
sociated with our estimates of the mental health burden
alone of lymphatic filariasis contrasts with the total bur-
den of 2.78 million attributed in the 2010 GBD study [1]
and the NTD reconciliation [2] of that study for NTD
diseases. We suggest that the burden of mental health,
using conservative estimates of the prevalence of mental
illness in LF, and the disability weights attributable to
depressive illness used in the GBD study suggest that
the burden of total LF is some three times the estimate
of 2.78 million DALYs and that mental health contrib-
utes to twice the burden of morbidity compared with
that published by GBD 2010 for lymphatic filariasis [1,
2]. It is possible that GBD reached this estimate by in-
cluding a prevalence number of 25 million – almost half
that of what we used. The GBD 2010 project obtained
estimates of prevalence using a Bayesian modeling soft-
ware. This method may result in prevalence estimate
that differs from those reported by the WHO.
We recognize there may be limitations in our estimates
as we used deterministic mathematical models that do not
incorporate stochastic methods to account for uncertainty
and we made assumptions in our calculations based on es-
timated prevalence and published literature combined with
several additional assumptions on the distribution of sever-
ity of depression. However, we consider that despite this
the burden of mental illness, which can be attributed to fil-
ariasis, has been grossly underestimated and that using this
approach to calculating the burden of mental illness should
be applied to other stigmatising NTD diseases [3] where
there are known to be psychiatric sequelae for patients and
their caregivers.
Having identified this often unrecognised area in de-
fining the true medical burden of an NTD like filariasis,
it is important to further comment on the need to estab-
lish appropriate methods to assess mental health at the
field level in these programmes. A number of tools are
available, such as the Mental Health Questionnaire
(MHI-5), the General Health Questionnaire (GHQ-12),
the Implicit Association test (IAT) for stigma assessment
and the Four Dimensional Symptom Questionnaire, for
distress and mental health in working populations.
Which tool is most appropriate needs investigation. It
should also be recognised that in NTDs there are two
levels of causation for a patient’s depression, that caused
by the stigma associated with the actual physical changes
caused by the disease (e.g. lymphoedema or hydrocele in
LF), and on a secondary level the further isolation and
depression resulting from being stigmatised as being
mentally affected by that primary LF –induced mental
illness. This underscores the complexnature of the men-
tal changes seen in NTD patients that need more com-
plicated, or at least special, investigation methods and
assessments. Focusing on appropriate ways of assessing
the mental health aspects of NTDs, as emphasised in
this discussion, will undoubtedly bring us close to truly
understanding the importance of this aspect of morbid-
ity management of this important group of global
diseases.
Conclusions
The burden of mental illness associated with neglected
tropical diseases has not been calculated. We have used
published literature of the prevalence of mental health in
lymphatic filariasis patients to calculate the Disability Ad-
justed Life Years (DALY) burden based on the most recent
estimates of global morbidity. We estimate that the burden
of mental illness due to depressive illness is 5.09 million
DALYS whilst the burden of mental illness in caregivers is
229,537 DALYS. These figures are approximately twice the
figure estimated in the 2010 GBD study for lymphatic filar-
iasis of 2.78 million DALYS. We consider that the burden
of mental illness of other NTDs needs to be assessed, as to
date, this crucial element of morbidity is not reported as a
contributor to the global burden of disease and no studies
have been undertaken on the burden of mental illness in
caregivers.
Appendix A
Global burden of depression caused by filariasis among
patients
A. Background information
Filariasis assumptions [17, 19]
 Number infected with lymphatic filariasis 67.88
million
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 Number with clinical illness 36.11 million
Genital hydrocele 19.43 million
Lymphodema 16.68 million
 Estimated with symptoms of depressive illness
18.1 million
 Of those with depression, 50 % had moderate or
severe 9.0 million
 GBD disability weight for filariasis 0.11
 Years of life lived with symptoms 20 years
B. Objective
Estimate the burden of depression caused by filariasis?
C. Overall DALY framework
Burden of any disease is mathematically estimated as:
DALY ¼ YLL þ YLD ð1Þ
where YLL = years lost to premature death caused by
that disease, and
where YLD = years lived with disability caused by that
disease
In this situation, we are interested in the burden of a par-
ticular disease, depression, that is specifically attributed to a
particular neglected tropical disease, filariasis.
We modified this mathematical formula for burden of
depression caused by filariasis such that the burden of
depression would be conditioned on filariasis as a cause:
DALY depression e filariasis½  ¼ YLL depression e filariasis½ 
þ YLD depression e filariasis½ 
ð2Þ
In other words, we estimated the burden of depression
caused only by filariasis (DALY[depression ~ filariasis]). Con-
ceptually, this quantity is a proportion of the overall
DALY for filariasis:
DALY depression e filariasis½  ¼ q  DALY filariasis½  ð3Þ
D. Component of DALY: years lived with disability
(YLD)
We know that mathematically:
YLD ¼ P x DW ð4Þ
where P = number of prevalent cases
where DW= disability weights
Within our context of filariasis and depression:
YLD depressionefilariasis½  ¼ P depressionefilariasis½ x DW depression½ 
ð5Þ
where = P[depression~filariasis] = prevalence of depression
among those with filariasis
where DW[depression~filariasis] = disability weights of having
depression
 50 % of those with filariasis suffer severely enough
to cause depression. Therefore, P = 20 million
 Eaton and colleagues used a weight of 0.35 for
major depressive disorders in the 1996 GBD
project.22 To provide a relative context of disability
weights, the following are weights noted by Eaton
and colleagues: quadriplegia is 0.90, for blindness is
0.62, for multiple sclerosis is 0.41, for deafness is
0.33, for rheumatoid arthritis is 0.21, and for watery
diarrhea is 0.07.
 In 2010, GBD estimated 3 separate disability
weights for mild, moderate and severe depressive
symptoms: 0.159, 0.406, 0.655.17
Assuming the distribution of mild, moderate, and se-
vere depression, we estimate the following components
for DALYs:
E. Component of DALY: Years of Life Lost (YLL)
The second component of DALYs is YLL:
YLL ¼ N x L ð6Þ
where N = number of deaths
where L = standard life expectancy at age of death
Within the context of filariasis and depression, we
modify the above formula accordingly:
YLL depressionefilariasis½ 
¼ N depressionefilariasis½ x L depressionefilariasis½ 
ð7Þ
Where N[depression~filariasis] = number of deaths from
depression caused by filariasis
Where L[depression~filariasis] = life expectancy of
depression caused by filariasis
Conceptually, the number of deaths caused by depression
attributed to filariasis, N[depression~filariasis], will be a number
of those who have depression caused by filariasis and who
go on to die as a result. According to GBD, no deaths oc-
curred as a result of depression in 2010. In addition, ac-
cording to the WHO, although filariasis is one of the
leading causes of disability, death from filariasis is rare.
Therefore, we will assume N[depression~filariasis] ~ 0
F. Calculating DALY from YLL + YDL
Parameter Estimate for
mild depression
Estimate for
moderate
depression
Estimate
for severe
depression
Sum
P 10 million 7 million 1 million 18. million
DW 0.159 0.406 0.655 n/a
YLD (=PxDW) 1.59 million 2.84 million 655,000 5.09 million
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If put all of our estimates together, we will have:
In summary, we estimate that the burden of depression
attributed to filariasis in 2010 is approximately 5.09 million.
Appendix B
Global burden of depression caused by filariasis among
caregivers
A. Background Information
Filariasis assumptions
 clinical sx 36.1 million
 prevalence of filariasis with very severe
symptoms 5 million
 number of caregivers of very severe filariasis
(1:1) 5 million
 proportion of caregivers who have depression
25 %
 years life lived with filarisis 20 years
B. Objective
Estimate the burden of depression caused by taking
care of an individual with severe filariasis.
C. Overall DALY framework
We know that the burden of any disease is mathem-
atically estimated as:
DALY ¼ YLL þ YLD ð8Þ
where YLL = years lost to premature death caused by
that disease, and
where YLD = years lived with disability caused by that
disease
In this situation, we want to know about the burden
on caregivers who take care of individuals with severe
filariasis.
Our mathematical formula for burden of depression
caused by taking care of an individual with severe filariasis
would have to be applied to caregivers, as opposed to
patients. We do not expect that caregivers to be fundamen-
tally different from other individuals in terms of experien-
cing disease burden; therefore, we apply the same formula
for disease burden for caregivers:
DALY depressionecaring for filariasis½ 
¼ YLL depressionecaring for filariasis½ 
þ YLD depressionecaring for filariasis½  ð9Þ
In other words, we are estimating the burden of de-
pression caused by caring for those with severe filariasis
(DALY[depression ~ caregiving for filariasis]).
D. Component of DALY: Years Lived With Disability
(YLD)
Calculation of YLD follows the formula:
YLD ¼ P x DW ð10Þ
where P = number of prevalent cases
where DW= disability weights
(This formula, YLD = P x DW, was used in GBD 2010
rather than what was used previously in earlier versions
of GBD methodology: YLD = I x DW x L).
Conceptually, this quantity is a proportion of the over-
all DALY of depression caused by caring for all other
conditions.
YLD depressionecaring for filariasis½ 
¼ P depressionecaring for filariasis½ x DW depression½  ð11Þ
where = P[depression~caring for filariasis] = number of
depression caused by caring for severe filariasis
where DW[depression~caring for filariasis] = disability weights
of depression
We obtained parameters from the literature and the
following assumptions:
 For P, the prevalence of caregivers of individuals
with filariasis is five million. We assumed that
25 % of these five million will have depression.
This estimate is obtained from literature on
prevalence of depression among caregivers for the
blind (48 %), and have reduced this proportion to
25 % for lympathic filarisis to obtain a conservative
estimate. As a result, P = 1,250,000 cases of
caregivers for filariasis who have depression.
 The burden of depression is given by disability
weights: 0.353
Here is a summary of our estimates:
The calculation of YLD from P and DW with 1.25 mil-
lion caregivers suffering from mild to moderate depression
is described below. We assumed that caregivers with severe
depression will select themselves out of the role of caregiv-
ing given the high disability associated with severe
depression:
YLL YLD (million) DALYs (million)
Disability from depression
attributed
to filariasis
0 5.09 5.09
Parameter Estimate or Range Comments
P 1.25 million 25 % of 5 million caregivers
assumed to have depression
DW for depression 0.159, 0.406, 0.655 Obtained from Salomon et al.
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E. Component of DALY: Years of Life Lost (YLL)
The second component of DALYs is YLL and is calcu-
lated as:
YLL ¼ N x L ð12Þ
Where N = number of deaths
Where L = standard life expectancy at age of death
Within the context of depression experienced by care-
givers of individuals with severe filariasis, we modify the
above formula accordingly:
YLL depressionecaring for filariasis½ 
¼ N depressionecaring for filariasis½ x L depressionecaring for filariasis½ 
ð13Þ
Where N[depression~caring for filariasis] = number of deaths
of caregivers of filariasis from depression
Where L[depression~caring for filariasis] = life expectancy of
caregivers of filariasis with depression
Conceptually, the number of deaths caused by de-
pression attributed to filariasis, N[depression~caring for fil-
ariasis], will be a number of those who have depression
caused by caring for individuals with severe filariasis
and who go on to die as a result. According to GBD, no
deaths occurred as a result of depression in 2010. We
also do not expect that caregiving is causes excess mor-
tality. Therefore, we will assume N[depression~caring for fil-
ariasis] ~ 0.
YLL depressionecaring for filariasis½ ¼ N depressionecaring for filariasis½ 
x L depressionefcaring for filariasis½ 
ð14Þ
YLL[depression~caring for filariasis] =0
F. Calculating DALY from YLL + YDL
From our calculations above:
DALY[depression~caring for filariasis] = YLL[depression~caring for
filariasis] + YLD[depression~caring for filariasis]
DALY[depression~caring for filariasis] = 0 + 229,637
DALY[depression~caring for filariasis] = 229,637
We estimate that the burden of depression on caregivers
of those with clinically symptomatic filariasis is 229,637.
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